THE WHITE HOUSE
Office of the Press Secretary
PRESIDENT NAMES ROBERT S. WARSHAW AS ASSOCIATE DIRECTOR OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY FOR THE BUREAU OF STATE AND LOCAL AFFAIRS
The President announced today his nomination of Robert S. Warshaw to serve as Associate Director of the Office of National Drug Control Policy for the Bureau of State and Local Affairs.
Robert S. Warshaw, of Rochester, New York, has had a career spanning four decades of leadership in civilian law enforcement and military service. He has established a national reputation for implementing community policing strategies by working extensively with federal, state, and local task forces across the United States to address the crime and violence associated with illegal drugs. Mr. Warshaw has been the Chief of Police in Rochester since 1994. From 1988-1994, he was Chief of Police in Statesville, North Carolina. From 1986-1988, he was Manager of Administration for the Department of Public Safety in Dekalb County, Atlanta, Georgia. From 1981-1985, he was Assistant Chief of Police in Miami, Florida. Mr. Warshaw is active in the International Association of Chiefs of Police and its Narcotics and Dangerous Drugs Committee, and has served on its Executive Committee. He is a member of the Police Executive Research Forum of Washington, D.C., and serves on its Legislative Committee.
Mr. Warshaw received a B.A. degree from Temple University and an M.S. degree from Biscayne College. He is also a graduate of the National Executive Institute of the Federal Bureau of Investigation.
The Office of National Drug Control Policy (ONDCP) was established in 1988 and is organized within the Executive Office of the President. ONDCP is authorized to develop and coordinate the policies, goals, and objectives of the nation's drug control program for reducing the use of illicit drugs. The Associate Director for the Bureau of State and Local Affairs serves as a principal advisor to the ONDCP Director, assists in oversight of the state and local policy requirements, and interfaces with all Federal agencies with drug control responsibilities.